Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.4M Buy
22,157
+100
+0.5% +$6.22K 0.98% 29
2020
Q4
$1.37M Hold
22,057
0.94% 31
2020
Q3
$1.33M Hold
22,057
0.97% 29
2020
Q2
$1.3M Sell
22,057
-400
-2% -$23.9K 0.97% 29
2020
Q1
$1.25M Buy
22,457
+200
+0.9% +$12.2K 1.09% 28
2019
Q4
$1.43M Sell
22,257
-300
-1% -$17.2K 1.02% 35
2019
Q3
$1.14M Hold
22,557
0.83% 38
2019
Q2
$1M Sell
22,557
-2,800
-11% -$130K 0.73% 39
2019
Q1
$1.21M Sell
25,357
-177
-0.7% -$8.82K 0.92% 37
2018
Q4
$1.33M Hold
25,534
1.11% 35
2018
Q3
$1.27M Sell
25,534
-100
-0.4% -$5.93K 1.03% 35
2018
Q2
$1.42M Sell
25,634
-100
-0.4% -$5.4K 1.14% 33
2018
Q1
$1.63M Buy
25,734
+442
+2% +$28.4K 1.34% 33
2017
Q4
$1.55M Sell
25,292
-1,350
-5% -$84.4K 1.22% 34
2017
Q3
$1.7M Hold
26,642
1.4% 33
2017
Q2
$1.48M Sell
26,642
-2,240
-8% -$122K 1.24% 34
2017
Q1
$1.57M Buy
28,882
+4,190
+17% +$230K 1.3% 32
2016
Q4
$1.44M Buy
24,692
+800
+3% +$43.7K 1.25% 32
2016
Q3
$1.29M Buy
23,892
+1,552
+7% +$99.7K 1.13% 35
2016
Q2
$1.64M Sell
22,340
-580
-3% -$41K 1.33% 30
2016
Q1
$1.46M Buy
22,920
+3,438
+18% +$217K 1.37% 29
2015
Q4
$1.34M Buy
+19,482
New +$1.29M 1.19% 30

Other funds holding BMY

Investment Counsel's BMY Position: Q1 2021 in Review

Investment Counsel increased its Bristol-Myers Squibb (BMY) stake by 0.45% in Q1 2021, buying an estimated $6.22K and bringing the position to 22,157 shares worth $1.4M. The position accounts for 0.98% of the portfolio, ranked #29.

Investment Counsel first reported a position in BMY in Q4 2015 and has held it in 22 quarters since. The position peaked at $1.7M in Q3 2017. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Investment Counsel held 22,157 shares of Bristol-Myers Squibb worth $1.4M as of Q1 2021.
  • Investment Counsel bought 100 Bristol-Myers Squibb shares in Q1 2021, an estimated $6.22K.
  • Bristol-Myers Squibb made up 0.98% of Investment Counsel's portfolio in Q1 2021, its #29 holding.
  • Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 22 quarters since.
  • Investment Counsel's Bristol-Myers Squibb position peaked at $1.7M in Q3 2017.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Investment Counsel's 13F filing for Q1 2021, filed 12 Apr 2021.